- Open
- 5.95
- High
- 5.99
- Low
- 5.95
- Close
- 5.98
- Change
- -0.05 (-0.84%)
- Volume
- 367,305
| 17 Sept 2026 | 07:00:01 | Half-year Financial Report |
| 15 Sept 2026 | 07:00:06 | OptiBiotix Ltd Directorate Changes |
| 8 Sept 2026 | 07:00:02 | SweetBiotix® Update |
| 2 Sept 2026 | 07:00:07 | H&B launches FORMI™ Product containing SlimBiome® |
| 26 Jun 2026 | 15:00:01 | Investor presentation and Q&A |
| 4 Jul 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
OptiBiotix Health plc is a life sciences company focused on developing products aimed at improving health through the gut microbiome. Its primary offerings include SlimBiome®, a weight management product that reduces hunger and cravings, and WellBiome®, a prebiotic fiber complex that enhances gut health and supports overall wellbeing. The company also develops SweetBiotix®, a natural sugar substitute, and microbiome modulators for various health applications. OptiBiotix operates globally, targeting consumers seeking healthier lifestyle choices and partners in the nutraceutical and pharmaceutical sectors.
| 17 Sept 2026 | 07:00:01 | Half-year Financial Report |
| 15 Sept 2026 | 07:00:06 | OptiBiotix Ltd Directorate Changes |
| 8 Sept 2026 | 07:00:02 | SweetBiotix® Update |
| 2 Sept 2026 | 07:00:07 | H&B launches FORMI™ Product containing SlimBiome® |
| 26 Jun 2026 | 15:00:01 | Investor presentation and Q&A |
| 4 Jul 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
OptiBiotix Health plc is a life sciences company focused on developing products aimed at improving health through the gut microbiome. Its primary offerings include SlimBiome®, a weight management product that reduces hunger and cravings, and WellBiome®, a prebiotic fiber complex that enhances gut health and supports overall wellbeing. The company also develops SweetBiotix®, a natural sugar substitute, and microbiome modulators for various health applications. OptiBiotix operates globally, targeting consumers seeking healthier lifestyle choices and partners in the nutraceutical and pharmaceutical sectors.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.72bn | +0.1% | |
| £144m | +0.1% | |
| £13m | -0.4% | |
| £10m | +0.2% | |
| £6m | -0.7% | |
OPTIOptibiotix Health plc | £6m | -0.4% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.72bn | +0.1% | |
| £144m | +0.1% | |
| £13m | -0.4% | |
| £10m | +0.2% | |
| £6m | -0.7% | |
OPTIOptibiotix Health plc | £6m | -0.4% |